A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and […]

Updated Date: Thu, 30 Mar 2023 00:00:00 EDT

Updated Date: Thu, 30 Mar 2023 00:00:00 EDT

Updated Date: Thu, 30 Mar 2023 00:00:00 EDT

Updated Date: Thu, 30 Mar 2023 00:00:00 EDT

Updated Date: Thu, 30 Mar 2023 00:00:00 EDT

Nanocages are tiny artificial containers that can be used to deliver therapeutics to a target destination in the […]

Researchers are studying the genes of superbugs to aid the development of new and effective treatments for drug-resistant […]

Data demonstrates a sound safety and tolerability profile for therapy during phase 1 clinical trial

Vital AstraZeneca therapy may transform lives of people with certain breast and prostate cancers